Weimar, Germany

Michael Bahr

This inventor holds 1 USPTO granted patent. Top assignee: Biomedical Apherese Systeme Gmbh. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Bahr. Retrieved from https://idiyas.com/inventor/michael-bahr-6ttrjkbt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 84(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Bahr - Innovator in Magnetic Nanoparticles

Introduction

Michael Bahr is a notable inventor based in Weimar, Germany. He has made significant contributions to the field of biomedical technology, particularly in the development of magnetic nanoparticles.

Latest Patents

Michael Bahr holds a patent for "Magnetic nanoparticles having biochemical activity, method for the production thereof and their use." This innovative work showcases his expertise in creating nanoparticles that can be utilized in various biomedical applications.

Career Highlights

Michael Bahr is currently employed at Biomedical Apherese Systeme GmbH, where he continues to advance his research and development efforts. His work focuses on enhancing the capabilities of biomedical technologies through innovative solutions.

Collaborations

Michael collaborates with esteemed colleagues, including Dimitri Berkov and Norbert Buske, who contribute to his research endeavors.

Conclusion

Michael Bahr's contributions to the field of magnetic nanoparticles highlight his role as an influential inventor in biomedical technology. His work continues to pave the way for advancements in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…